HOME Press Releases Life Science Instrumentation Market worth 64.52 Billion USD by 2021



Life Science Instrumentation Market worth 64.52 Billion USD by 2021


The report "Life Science Instrumentation Market by Technology (Chromatography, Flow Cytometer, Spectroscopy, PCR, Microscopy), End User (Pharmaceutical & Biotechnology Companies, CROs, Hospitals), Application (Research, Clinical & Diagnostic) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Browse 96 market data Tables and 89 Figures spread through 320 Pages and in-depth TOC on "Life Science Instrumentation Market by Technology (Chromatography, Flow Cytometer, Spectroscopy, PCR, Microscopy), End User (Pharmaceutical & Biotechnology Companies, CROs, Hospitals), Application (Research, Clinical & Diagnostic) - Global Forecast to 2021"
http://www.marketsandmarkets.com/Market-Reports/life-science-chemical-biotech-instrumentation-market-38.html
Early buyers will receive 10% customization on reports.

This report studies the global life science instrumentation market over the forecast period of 2016 to 2021. The market is expected to reach USD 64.52 Billion by 2021, at CAGR of 6.8% from 2016 to 2021. A number of factors such as increasing spending on pharmaceutical R&D, growing food safety concerns, availability of public and private funding for life science research, and continuous technological advancements in analytical instruments are fueling the growth of the life science instrumentation market. On the other hand, presence of alternative analytical technologies, high cost of instruments, and need for skilled professionals are some of the key factors limiting the growth of the global life science instrumentation market.

Based on the type of technology, the global life science instrumentation market is divided into thirteen segments, namely, cell counting, centrifuges, chromatography, electrophoresis, flow cytometry, immunoassays, liquid handling and robotics, microscopy, next-generation sequencing, PCR, spectroscopy, western blotting, and other technologies. The other technologies segment includes heat sterilization, colorimeter, fume hoods, incubators, laboratory balances, microplate systems, and laboratory freezers.

On the basis of end users, the global life science instrumentation market is segmented into pharmaceutical and biotechnology companies; CROs; research institutions; hospitals, clinics, and diagnostic laboratories; academic institutions; forensic science laboratories; food and agriculture industry; environmental testing industry; and other end users. On the basis of applications, the life science instrumentation market is segmented into research applications; clinical and diagnostic applications; and other applications. The other applications segment comprises food and beverage testing, environmental testing, industrial chemistry, forensics, cosmetic industry, and petrochemical industry.

As of 2016, North America held the largest share of the global life science instrumentation market, followed by Europe. However, the Asia-Pacific market is expected to register the highest CAGR of 8.6% from 2016 to 2021. Factors such as strategic expansions by key market players in emerging Asian countries; growing pharmaceutical industry in India and China; and increasing government investment in biomedical industry in China and Singapore are stimulating the growth of the life science instrumentation market in the Asia-Pacific region.

Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.) are some of the key players operating in the global life science instrumentation market.

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&Ms flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports